|
Status
|
Topic selection
|
|
Technology type
|
Medicine
|
|
Decision
|
Not selected
|
|
Reason for decision
|
Not eligible for Health Technology Evaluation guidance
|
|
Further information
|
Dear stakeholders,
For information, the company have advised that they are no longer pursuing a Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme.
|
| ID number |
11961
|
Project Team
| Project lead |
Danielle Lees |
Email enquiries
For further information on how we select topics for development, please see our page about topic selection